Resistant Blood Cancers with Iclusig 45mg Tablet
New

Useful for those patients who are having specific blood cancer that are resistant to other therapies. This targeted therapy helps control abnormal cell growth by blocking disease causing signals. Although, healthcare experts primarily prescribes Iclusig 45mg Tablet for Multiple Blood Cancer such as Chronic Myeloid Leukemia (CML) or Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL). Visit Globans Pharma for more such information.

Location

2115, Burlington Tower, Business Bay, Dubai, UAE,Poughkeepsie,New York

Leave feedback about this

  • Quality
  • Price
  • Service